Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Aragen, Innovent in Bio-Development Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Aragen, Innovent in Bio-Development Pact

To develop CHO cell lines and assess product attributes for proteins

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Aragen Bioscience and Innovent Biologics have entered a collaboration for the development and manufacture of cell lines for biotherapeutic product development. Aragen Bioscience will develop CHO cell lines and assess critical product quality attributes for various antibodies and protein therapeutics.
           
“Aragen Bioscience has demonstrated expertise in cell line development and protein product characterization. We recently completed the first technology transfer of the collaboration and are continuing with multiple additional products,” said Michael Yu, chief executive officer of Innovent.
 
“Innovent is a great partner for the clinical development of biologic products expressed by the cell lines we have generated. We look forward to the expansion of the collaboration,” said Oren Beske, Ph.D., vice president of Aragen Bioscience.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics